Amarin Corp PLC (AMRN): Net Income
-$38.80M
Year ended 2025-12-31
-$27.12M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$38.80M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$82.18M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$59.11M | n/m | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | -$105.80M | n/m | 2025-03-12, From 2022-01-01 |
| 2021-12-31 | $7.73M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$18.00M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | -$22.64M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$116.44M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$67.86M | n/m | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | -$86.35M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$115.20M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$56.36M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$166.23M | n/m | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | -$179.18M | n/m | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | -$69.13M | n/m | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | -$249.59M | n/m | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | -$30.61M | n/a | 2012-02-29, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Amarin Corp PLC (AMRN) | 2025-12-31 | -$38.80M | n/m |
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | -$220.47M | n/m |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | -$113.70M | n/m |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $31.11M | +2.8% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | -$13.23M | n/m |
| Akebia Therapeutics, Inc. (AKBA) | 2025-12-31 | -$5.34M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$196.54M | n/m |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $87.01M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$130.77M | n/m |
Compare AMRN, VNDA, IDYA, PBYI side by side · Screen every company in Pharmaceutical Preparations ↗